# Chronic intermittent hypoxia reshapes circadian metabolic architecture in a model of sleep apnea

**Authors:** Emilie Montellier, Guillaume Vial, Sophie Bouyon, Kousha Changizi Ashtiani, Sherif Abdelkarim, Emeline Lemarie, Antoine Boutin, Kenichiro Kinouchi, Pierre Baldi, Jean-Louis Pépin, Jonathan Gaucher

PMC · DOI: 10.1126/sciadv.aeb3756 · Science Advances · 2026-02-25

## TL;DR

Chronic intermittent hypoxia from sleep apnea disrupts daily metabolic rhythms in the liver and body, shifting metabolism to conserve oxygen.

## Contribution

The study reveals how chronic hypoxia acts as a circadian zeitgeber, reprogramming metabolic pathways through the cAMP-CREB1 pathway.

## Key findings

- Chronic IH alters circadian regulation of glucose, lipid, and redox metabolism in a time-specific manner.
- Metabolic shifts include increased gluconeogenesis, glycogen turnover, and lipid mobilization during hypoxia.
- The cAMP-CREB1 pathway is identified as a key driver of circadian transcriptional changes in the liver.

## Abstract

Obstructive sleep apnea (OSA), characterized by chronic intermittent hypoxia (IH) during sleep, is increasingly recognized as a driver of metabolic dysfunction. However, its impact on circadian metabolic regulation remains poorly understood. Here, we investigated how chronic IH reshapes 24-hour hepatic and systemic metabolic programs in a mouse model mimicking OSA-associated chronic hypoxia. Through integrated circadian transcriptomic, metabolomic, and physiological 24-hour profiling, we show that 4 weeks of rest phase–restricted IH reprograms hepatic and systemic metabolism in a time-specific manner. This reorganization involves the coordinated circadian regulation of glucose, lipid, and redox pathways, with a shift away from oxidative metabolism toward oxygen-sparing processes such as gluconeogenesis, glycogen turnover, and lipid mobilization. These changes align with the hypoxic phase exposure and coincide with reshaped hepatic metabolite oscillations and systemic autonomic rhythms, supporting a functional adaptation to intermittent oxygen availability. Mechanistically, we identify the cAMP-CREB1 pathway as a driver of circadian transcriptional remodeling in the liver and a central integrator of IH-dependent adrenergic stress. Our findings establish chronic IH as a potent metabolic zeitgeber that rewires hepatic transcriptional and metabolic programs, revealing a circadian dimension to the metabolic consequences of sleep-disordered breathing.

Sleep apnea reprograms circadian metabolism.

## Linked entities

- **Genes:** CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385]
- **Diseases:** Obstructive sleep apnea (MONDO:0007147), sleep apnea (MONDO:0005296)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, Fasn (fatty acid synthase) [NCBI Gene 14104] {aka A630082H08Rik, FAS}, Hmgcr (3-hydroxy-3-methylglutaryl-Coenzyme A reductase) [NCBI Gene 15357] {aka HMG-CoAR, Red}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, Pygl (liver glycogen phosphorylase) [NCBI Gene 110095], Bmal1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 11865] {aka Arnt3, Arntl, BMAL1b, MOP3, bHLHe5, bmal1b'}, Nr1d1 (nuclear receptor subfamily 1, group D, member 1) [NCBI Gene 217166] {aka A530070C09Rik}, Cpt2 (carnitine palmitoyltransferase 2) [NCBI Gene 12896] {aka CPTII}, Cry1 (cryptochrome circadian regulator 1) [NCBI Gene 12952] {aka Phll1}, Clock (clock circadian regulator) [NCBI Gene 12753] {aka 5330400M04Rik, KAT13D}, Fbp1 (fructose bisphosphatase 1) [NCBI Gene 14121] {aka Fbp-2, Fbp2, Fbp3}, Camp (cathelicidin antimicrobial peptide) [NCBI Gene 12796] {aka CAP18, CLP, Cnlp, Cramp, FALL39, MCLP}, Nr1d2 (nuclear receptor subfamily 1, group D, member 2) [NCBI Gene 353187] {aka RVR, Rev-erb}, Gck (glucokinase) [NCBI Gene 103988] {aka GLK, Gk, Gls006, HK4, HKIV, HXKP}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, Pik3r6 (phosphoinositide-3-kinase regulatory subunit 6) [NCBI Gene 104709] {aka p84, p84 PIKAP, p87(PIKAP), p87PIKAP}, G6pc1 (glucose-6-phosphatase catalytic subunit 1) [NCBI Gene 14377] {aka G6Pase, G6pc, G6pt, Glc-6-Pase}, Gys2 (glycogen synthase 2) [NCBI Gene 232493] {aka LGS}, Pck1 (phosphoenolpyruvate carboxykinase 1, cytosolic) [NCBI Gene 18534] {aka PEPCK, PEPCK-C, Pck-1}, Cyp7a1 (cytochrome P450, family 7, subfamily a, polypeptide 1) [NCBI Gene 13122] {aka CYPVII, CYPVIIc}, Idh3a (isocitrate dehydrogenase 3 (NAD+) alpha) [NCBI Gene 67834] {aka 1110003P10Rik, 1500012E04Rik}, Ldha (lactate dehydrogenase A) [NCBI Gene 16828] {aka Ldh1, Ldhm, l7R2}, Per2 (period circadian clock 2) [NCBI Gene 18627] {aka mKIAA0347, mPer2}, Cox6a1 (cytochrome c oxidase subunit 6A1) [NCBI Gene 12861] {aka VIaL}
- **Diseases:** OSA (MESH:D020181), liver injury (MESH:D017093), Sleep apnea (MESH:D012891), hyperglycemic (MESH:D006944), hypoxic (MESH:D002534), arrhythmias (MESH:D001145), arrhythmic (OMIM:212500), metabolic dysfunction (MESH:D008659), chronic intermittent hypoxia (MESH:D000860), liver disease (MESH:D008107), sleep disorder (MESH:D012893)
- **Chemicals:** 3'-deoxythymidine 5'-triphosphate (MESH:C017216), citrate (MESH:D019343), carbon dioxide (MESH:D002245), ATP (MESH:D000255), sterol (MESH:D013261), lipid (MESH:D008055), pyrophosphate (MESH:C107241), fumarate (MESH:D005650), NAD (MESH:D009243), buprenorphine (MESH:D002047), poly(A) (MESH:D011061), reactive oxygen species (MESH:D017382), magnesium (MESH:D008274), Glucose (MESH:D005947), ubiquinone Q1 (MESH:C025203), QH2 (-), amino acid (MESH:D000596), heme (MESH:D006418), deoxyuridine triphosphate (MESH:C027078), phenylmethylsulfonyl fluoride (MESH:D010664), catecholamine (MESH:D002395), arginine (MESH:D001120), fatty acid (MESH:D005227), carbohydrate (MESH:D002241), succinyl-CoA (MESH:C012046), l-serine (MESH:D012694), nicotinamide (MESH:D009536), water (MESH:D014867), trichostatin A (MESH:C012589), TRIzol (MESH:C411644), NaF (MESH:D012969), Glycogen (MESH:D006003), isoflurane (MESH:D007530), adenine (MESH:D000225), isopropanol (MESH:D019840), SDS (MESH:D012967), Blood glucose (MESH:D001786), cholesterol (MESH:D002784), nitric oxide (MESH:D009569), ethanol (MESH:D000431), NaCl (MESH:D012965), sodium deoxycholate (MESH:D003840), methanol (MESH:D000432), succinate (MESH:D019802), Pyruvate (MESH:D019289), Oxygen (MESH:D010100), diethyl pyrocarbonate (MESH:D004047), nitrogen (MESH:D009584), choline (MESH:D002794), orotate (MESH:D009963), xylazine (MESH:D014991), Renaudin (MESH:D008614), NP40 (MESH:C010615), lactate (MESH:D019344), polyacrylamide (MESH:C016679), Adrenaline (MESH:D004837), thymine (MESH:D013941), TCA (MESH:D014233), triglyceride (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935056/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935056/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935056/full.md

---
Source: https://tomesphere.com/paper/PMC12935056